These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 987530)

  • 1. Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia.
    Siggers DC; Rogers JG; Boyer SH; Margolet L; Dorkin H; Banerjee SP; Shooter EM
    N Engl J Med; 1976 Sep; 295(12):629-34. PubMed ID: 987530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve-growth factor in familial dysautonomia.
    Levi-Montalcini R
    N Engl J Med; 1976 Sep; 295(12):671-3. PubMed ID: 972645
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J; Vroegop SM; Buxser SE; Neet KE
    J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor (NGF) in serum: evaluation of serum NGF levels with a sensitive bioassay employing embryonic sensory neurons.
    Stephani U; Sutter A; Zimmermann A
    J Neurosci Res; 1987; 17(1):25-35. PubMed ID: 3573079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against mouse nerve growth factor produced by somatic cell hybrids.
    Businaro R; Butler RH; Rubenstein AE; Revoltella RP
    J Neurosci Res; 1981; 6(1):89-98. PubMed ID: 7218374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antibodies to synthetic nerve growth factor (NGF) and proNGF peptides.
    Ebendal T; Persson H; Larhammar D; Lundströmer K; Olson L
    J Neurosci Res; 1989 Mar; 22(3):223-40. PubMed ID: 2468788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene related peptide in familial dysautonomia.
    Maayan C; Becker Y; Gesundheit B; Girgis SI
    Neuropeptides; 2001; 35(3-4):189-95. PubMed ID: 11884210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient sympathetic nervous response in familial dysautonomia.
    Ziegler MG; Lake CR; Kopin IJ
    N Engl J Med; 1976 Mar; 294(12):630-3. PubMed ID: 1246255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered nerve growth factor in fibroblasts from patients with familial dysautonomia.
    Schwartz JP; Breakefield XO
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1154-8. PubMed ID: 6244581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioassay detection of mouse nerve growth factor (mNGF) in the brain of adult mice.
    Scott SM; Tarris R; Eveleth D; Mansfield H; Weichsel ME; Fisher DA
    J Neurosci Res; 1981; 6(5):653-8. PubMed ID: 7033556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor.
    Muir D
    Exp Cell Res; 1994 Feb; 210(2):243-52. PubMed ID: 8299723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-site enzyme immunoassay for beta NGF applied to human patient sera.
    Lorigados L; Söderström S; Ebendal T
    J Neurosci Res; 1992 Jul; 32(3):329-39. PubMed ID: 1433383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-nerve growth factor measurements in mouse serum.
    Lakshmanan J
    J Neurochem; 1986 Mar; 46(3):882-91. PubMed ID: 3950612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma levels of substance P in vernal keratoconjunctivitis.
    Lambiase A; Bonini S; Micera A; Tirassa P; Magrini L; Bonini S; Aloe L
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2161-4. PubMed ID: 9331280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic sites on mouse 2.5S nerve growth factor.
    Butler RH; Revoltella RP
    Mol Immunol; 1982 Feb; 19(2):323-7. PubMed ID: 6178958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells.
    Sutter A; Riopelle RJ; Harris-Warrick RM; Shooter EM
    J Biol Chem; 1979 Jul; 254(13):5972-82. PubMed ID: 571871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early days of the nerve growth factor proteins.
    Shooter EM
    Annu Rev Neurosci; 2001; 24():601-29. PubMed ID: 11283322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of monoclonal antibodies against human nerve growth factor.
    Okishio M; Iwane M; Igarashi K; Ichimori Y
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1474-80. PubMed ID: 8250905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells.
    Lambiase A; Bonini S; Bonini S; Micera A; Magrini L; Bracci-Laudiero L; Aloe L
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2127-32. PubMed ID: 7657550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuronal growth factor levels in von Recklinghausen's neurofibromatosis.
    Riopelle RJ; Riccardi VM; Faulkner S; Martin MC
    Ann Neurol; 1984 Jul; 16(1):54-9. PubMed ID: 6431898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.